|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 16 August 2006
doi: 10.1242/dev.02539
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

1 Program in Cardiovascular Sciences, Baylor College of Medicine, Houston, TX
77030, USA.
2 Department of Pediatrics (Cardiology), Baylor College of Medicine, Houston, TX
77030, USA.
3 Department of Molecular and Human Genetics, Baylor College of Medicine,
Houston, TX 77030, USA.
Author for correspondence (e-mail:
abaldini{at}ibt.tamhsc.edu)
Accepted 18 July 2006
| SUMMARY |
|---|
|
|
|---|
Key words: Tbx1, Fgf8, DiGeorge syndrome, 22q11DS, Mesoderm, Anterior heart field, Pharyngeal development, Cardiac outflow tract, Thymus, Mouse
| INTRODUCTION |
|---|
|
|
|---|
Tbx1 encodes a transcription factor of the T-box gene family. The
gene is haploinsufficient in humans, and is thought to play a major role in
the pathogenesis of DiGeorge syndrome
(Jerome and Papaioannou, 2001
;
Lindsay et al., 2001
;
Merscher et al., 2001
;
Yagi et al., 2003
).
Investigators have accumulated a substantial amount of data supporting
interactions between Tbx1 and major signaling systems such as the fibroblast
growth factor (FGF) (Hu et al.,
2004
; Vitelli et al.,
2002b
; Xu et al.,
2004
), hedgehog (Yamagishi et
al., 2003
), retinoic acid
(Guris et al., 2006
;
Roberts et al., 2005
) and
vascular endothelial growth factor
(Stalmans et al., 2003
)
signaling. These reports underscore the intricacy of the role of Tbx1 in
mammalian embryonic development. We and others have initiated an extensive
dissection of the mouse mutant phenotype using conditional time- and
tissue-specific ablation and dose manipulation
(Arnold et al., 2006
;
Hu et al., 2004
;
Liao et al., 2004
;
Xu et al., 2005
;
Xu et al., 2004
;
Zhang et al., 2005
). Results
indicated that at all developmental times and in most tissues tested there is
a crucial role for Tbx1, and that different structures have different
sensitivity to Tbx1 dose.
Tbx1 is mainly expressed in tissues that form the embryonic
pharyngeal system, i.e. surface ectoderm, pharyngeal endoderm, head
mesenchyme, core mesoderm, splanchnic mesoderm, but not neural crest-derived
mesenchyme (Chapman et al.,
1996
; Vitelli et al.,
2002a
). The pharyngeal endoderm expression domain has stimulated
considerable attention because of its dynamic nature, and because mutants have
hypoplasia and defective segmentation of the pharynx
(Jerome and Papaioannou, 2001
;
Lindsay et al., 2001
;
Vitelli et al., 2002a
).
Indeed, Tbx1 ablation reduces the proliferation of endodermal cells
(Xu et al., 2005
), while
heterozygous ablation of the gene in pharyngeal epithelia (ectoderm and
endoderm but not in the mesoderm) causes vascular abnormalities characteristic
of the Tbx1 haploinsufficiency phenotype
(Zhang et al., 2005
). In
addition, it has been shown that homozygous, conditional ablation of
Tbx1 by the Foxg1Cre driver, which induces
recombination predominantly in the pharyngeal endoderm, causes a mutant
phenotype similar to that of germ line null mutants. However, tissues that
express Tbx1 interact closely during development, raising the issue
of whether Tbx1 may be required in multiple tissues to contribute to
morphogenesis of the pharyngeal system. In this study, we use a novel
approach, i.e. tissue-specific re-activation of the gene in a mutant
background, as well as classic tissue-specific gene ablation, to address this.
Results show that most of the developmental defects generated by null mutation
of Tbx1 are recapitulated by mesodermal-specific somatic deletion of
the gene, while mesodermal reactivation of the gene in a mutant background
rescues most of those defects. Our data revealed a previously unknown
instructive role of mesoderm in patterning pharyngeal segmentation. In
addition, the combination of tissue-specific ablation and tissue-specific
re-activation revealed different requirements of Tbx1 expression in
the development of different pharyngeal structures. Our in vivo analysis
suggests that mesodermal Tbx1 expression supports proliferation and
regulates the expression of Fgf8 in the splanchnic mesoderm/anterior
heart field.
| MATERIALS AND METHODS |
|---|
|
|
|---|
The following mouse mutant alleles used in this study have been reported
previously: Tbx1flox,
Tbx1
E5, Tbx1mcm
(Xu et al., 2004
),
Tbx1lacZ (Lindsay et
al., 2001
), Mesp1Cre
(Saga et al., 1999
) and R26R
(Soriano, 1999
). All lines
were backcrossed into the C57Bl/6 genetic background for at least two
generations. PCR strategies for mouse genotyping have been described in the
original reports.
The Tbx1neo2 allele was generated by gene targeting in AB2.2 ES cells, as shown in Fig. 3A. A loxP-flanked PGKneo cassette (neomycin resistant gene driven by the PGK promoter) was inserted in an intron between exon 5 and exon 6 of Tbx1 by homologous recombination. ES cells were injected into C57BL/6 blastocysts and chimeric mice were crossed with C57BL/6 mice to obtain germ line transmission of the mutant allele. The Tbx1neo2 allele was genotyped with primer pair 5'-GCCAGAGGCCACTTGTGTAG-3' and 5'-AGGCTGGGATTCCAAAAGAC-3'.
Quantification of Tbx1 expression level
Quantification of Tbx1 expression was carried out using the TaqMan
Gene Expression Assay system (Applied Biosystem) on total RNA extracted from
E9.5 wild-type, Tbx1neo2/+,
Tbx1neo2/neo2 and Tbx1neo2/- embryos.
We used commercially available probe and primer sets (assay IDs are
Mm01342800_gH for Tbx1 and Mm00607939_s1 for the ß-actin
control).
Tamoxifen-induced Cre recombination
We used an inducible allele Tbx1mcm/+ to map the
distribution of Tbx1-expressing cells during embryogenesis as
previously described (Xu et al.,
2005
). We injected tamoxifen (Sigma) intraperitoneally into
pregnant female (75 mg/kg body weight) at E6.5 and half this dose on the
following 2 days.
Morphological analysis
Aortic arch arteries and hearts of E18.5 embryos were isolated by manual
dissection and photographed under a stereomicroscope. Hearts were embedded,
sectioned and stained with Hematoxylin and Eosin. Earlier embryos were
examined under the stereomicroscope, fixed and embedded in paraffin for
histological analysis. Intracardiac ink injection was performed to visualize
pharyngeal arch arteries at E10.5. Embryos were then fixed and dehydrated in
ethanol:water:acetic acid:chloroform (95:3:1:1) solution and cleared in methyl
salicylate:benzyl benzoate (50:50) solution. ß-Galactosidase activity was
revealed by staining paraformaldehyde-fixed embryos with the X-gal substrate,
according to standard procedures. Stained whole-mount embryos were
photographed and then embedded in paraffin and cut into 10 µm histological
sections. Sections were counterstained with Nuclear Fast Red.
RNA in situ hybridization and immunohistochemistry
Whole-mount and tissue section RNA in situ hybridization with
nonradioactive probes was performed as previously described
(Albrecht et al., 1997
), using
probes for Pax1 (kindly provided by Dr R. Balling), Tbx1
(from Dr V. Papaioannou), Crabp1
(Giguere et al., 1990
) and
Fgf8 (from Dr G. Martin). The anti Hoxb1 antibody has been kindly
provided by Dr N. Manley. The anti neurofilament-M monoclonal antibody 2H3 was
obtained from the Developmental Studies Hybridoma Bank. Anti Hoxb1 and
neurofilament-M were used in whole-mount immunohistochemistry. Proliferating
cells were labeled by immunohistochemistry on paraffin-embedded sections using
an anti phosphorylated histone H3 antibody (Upstate) and assayed on three
controls and three conditional mutants. Tissue-specific deletion and
restoration of Tbx1 expression was confirmed by immunofluorescence on
cryosections with an anti Tbx1 antibody (Zymed).
| RESULTS |
|---|
|
|
|---|
E5/+
mice with Tbx1flox/flox mice. Immunohistochemistry using
an anti Tbx1 antibody confirmed the loss of the protein in mesodermally
derived tissues but not in the endoderm of
Mesp1cre/+;Tbx1
E5/flox
embryos at E9.5 (Fig. 1C,D),
although we did detect some residual Tbx1 immunoreactivity in the core of the
1st pharyngeal arch (arrow in
Fig. 1D). At E9.0, we obtained
a similar result and confirmed the preservation of the ectodermal signal
(Fig. 1E-F). Thus,
Mesp1Cre-driven deletion is specific for the mesoderm and
does not affect (directly or indirectly) epithelial expression of
Tbx1.
Mesodermal deletion of Tbx1 causes severe phenotypic abnormalities
We examined the morphological phenotype of Mesp1cre/+;
Tbx1
E5/flox embryos (hereafter
referred to as M-ko) at different developmental stages. At E18.5, M-ko embryos
(n=15) exhibited a phenotype very similar to that observed in
Tbx1-/- embryos. In particular, M-ko embryos had
hypoplastic external ears (15/15, Fig.
2A,A'), thymic aplasia or severe hypoplasia (12/15 and 3/15,
respectively, Fig.
2B,B'), persistent truncus arteriosus (PTA) and ventricular
septal defects (VSD) (15/15, Fig.
2C-D'), as well as aortic arch defects (15/15,
Fig. 2C,C'). However,
with one exception, M-ko embryos did not exhibit cleft palate, a common
feature of Tbx1-/- mutants (not shown). At E10.5, M-ko
embryos (n=15) presented with hypoplasia of the 2nd pharyngeal arches
(Fig. 2E,E'), loss of the
3rd, 4th and 6th pharyngeal arches and pharyngeal arch arteries (PAA)
(Fig. 2F,F'), and severe
hypoplasia of the pharynx (Fig.
2G,G'). RNA in situ hybridization with Pax1, a
marker of pharyngeal pouch endoderm, showed no labeling of the 2nd and 3rd
pharyngeal pouches of M-ko embryos (Fig.
2J,J'), while the 4th pouch, identified by
immunohistochemistry with an anti Hoxb1 antibody, appeared to be smaller
(Fig. 2K,K') though not
as severely affected as that of null mutants (data not shown). These data
suggest that Tbx1 in the mesoderm regulates a signaling pathway required for
pharyngeal endoderm development.
|
Generation of a Cre-activatable Tbx1 allele
Tissue-specific deletion can determine if an expression domain is
necessary, but not if it is sufficient, for a particular developmental
process. As Tbx1 is expressed in multiple interacting tissues during
pharyngeal development, it is reasonable to hypothesize that the gene may be
necessary in multiple tissues to contribute to the complex morphogenesis of
pharyngeal derivatives. To address this hypothesis, we designed and generated
a new allele of Tbx1 that has a low expression level but that can be
reverted to wild-type level upon Cre recombination. To this end, we inserted a
loxP-flanked PGKneo cassette into intron 5 by homologous recombination
(Fig. 3A) and established the
allele (Tbx1neo2) in mice. We used quantitative real-time
PCR to evaluate the amount of Tbx1 mRNA in
Tbx1neo2/- embryos at E9.5 and estimated that
the allele produced
20% of the wild-type mRNA level (data not shown). To
establish whether there may be tissue-specific differences in Tbx1
mRNA or protein expression, we used RNA in situ hybridization (not shown) and
immunofluorescence on frozen section (Fig.
3B). With both techniques, we observed homogeneous, strong
reduction of the signal without any obvious tissue differences. We predicted
that removal of the PGKneo cassette by Cre recombination (generating the
allele Tbx1neo2
) would revert this
allele to a functionally `normal' allele. Indeed,
Tbx1neo2
/neo2
animals where viable, apparently normal and fertile (not shown). By contrast,
Tbx1neo2/+ and
Tbx1neo2/
E5 animals presented with
abnormalities similar to those observed in
Tbx1
E5/+ and
Tbx1
E5/
E5
animals, respectively, as detailed below. To test whether the neo2
allele could be reactivated in a tissue-specific manner, we crossed
Mesp1Cre/+;Tbx1
E5/+
with Tbx1neo2/+ animals and carried out
immunofluorescence on Tbx1neo2/
E5 and
Mesp1Cre/+;Tbx1neo2/
E5
E9.5 embryos, using an anti Tbx1 antibody on frozen sections. Results showed
that although Tbx1neo2/
E5 embryos had
near-background signal levels,
Mesp1Cre/+;Tbx1neo2/
E5
embryos had a robust signal in mesodermal tissues
(Fig. 3B,B'). Thus,
Tbx1neo2 is a hypomorphic allele that reverts to a
functional allele upon Cre recombination in vivo. Because
Mesp1Cre-induced recombination precedes the onset of Tbx1
expression, it is predictable that the reactivation of the allele occurs from
the onset of Tbx1 expression.
|
|
E5 embryos exhibited
phenotypic abnormalities of the same type as those seen in
Tbx1
E5/
E5 embryos, although in some cases
with a milder expressivity. Specifically, the cardiovascular phenotype was
very severe (n=20) and included PTA, aortic arch defects
(Fig. 3E) and VSD
(Fig. 3F). No thymus
(n=17) could be observed except for three embryos that exhibited
severe hypoplasia (Fig. 3D).
The external ear (n=20) and the second pharyngeal arch
(n=23) were hypoplastic (Fig.
3C,G). The latter two phenotypic abnormalities were present with
different levels of severity but were never absent. The pharynx was
hypoplastic and the 3rd, 4th, and 6th pharyngeal arches were not segmented
(Fig. 3I). The 4th PAAs were
absent in all the mutants (n=23), and the 3rd and/or 6th PAA were
missing in one or both sides (Fig.
3H). Reactivation of mesodermal expression of Tbx1 in
Mesp1Cre/+;Tbx1neo2/
E5
embryos rescued completely the OFT defects (PTA and VSD,
Fig. 3E',F'), the
formation and remodeling of the 3rd and 6th pharyngeal arch arteries
(Fig. 3H',I'), and
the hypoplasia of the 2nd pharyngeal arch and of the external ear
(Fig. 3C',G'), but
it did not rescue the thymic aplasia (Fig.
3D') or the 4th pharyngeal arch and 4th PAA aplasia
(Fig. 3H',I'). The
pharyngeal patterning defects were partially rescued.
Tbx1neo2/
E5 embryos had a hypoplastic
2nd pharyngeal pouch and no detectable 3rd pouch, as detected by Pax1
expression (Fig. 3J).
Mesodermal reactivation was associated with normalized 2nd pouch signal and
partial 3rd pouch signal (Fig.
3J', compare with Fig.
2J for wild-type pattern). The 4th pharyngeal pouch (as revealed
by Hoxb1 immunohistochemistry), was very hypoplastic in
Tbx1neo2/
E5 embryos but was partially
rescued by mesodermal reactivation of Tbx1
(Fig. 3K,K'). Finally,
the neural crest migration and cranial nerve pathway abnormalities observed in
Tbx1neo2/
E5 embryos were only marginally
improved by mesodermal reactivation (Fig.
3L,L',M,M', compare with
Fig. 2H,I for wild-type
patterns).
|
Mesodermal expression of Tbx1 is required to maintain proliferation and Fgf8 expression cell autonomously
Having defined the mesoderm-specific developmental roles of Tbx1, we asked
how these roles may be effected. Timed deletion of Tbx1 has shown
that the structures affected by mesodermal-specific gene ablation require
Tbx1 approximately between E8.0 and E9.0
(Xu et al., 2005
). We,
therefore, focused our attention on E8.5 M-ko embryos. The Tbx1 gene
is turned on at approximately E8 in the paraxial mesoderm, and in the adjacent
ectoderm and endoderm (Fig.
4A,A'). At these stages, M-ko mutants were indistinguishable
from controls. However, immunostaining with anti-phospho H3 antibody, which
detects mitotic cells, showed that mutants had severely reduced mitotic
activity (Fig. 4B,B',E).
By contrast, immunostaining with an anti-cleaved caspase 3 antibody did not
reveal changes in apoptotic activity (data not shown). It has been shown that
Tbx1 interacts with and may directly regulate Fgf8 gene
expression (Hu et al., 2004
;
Vitelli et al., 2002b
), and
loss of Fgf8 can downregulate mitotic activity in pharyngeal mesoderm
(Park et al., 2006
).
Therefore, we tested Fgf8 expression in M-ko mutants at E8.5, E9.0
and E9.5. At all stages tested, the pharyngeal epithelial expression of
Fgf8 was conserved (with the caveat that the pharynx of M-ko embryos
is hypoplastic, and, therefore, expression domains appear proportionally
smaller) (Fig. 5). By contrast,
the early splanchnic mesoderm/anterior heart field domain detectable at E8.5,
was lost or strongly downregulated (Fig.
5A'-B'). This region also expresses Tbx1
(Nowotschin et al., 2006
;
Zhang et al., 2005
).
Shh expression was maintained at all the stages tested (E8.5, E9.0
and E9.5, not shown). Thus, reduced proliferation of mesenchymal cells in M-ko
embryos may be secondary to downregulation of autocrine Fgf8 signaling, but it
is unlikely to be secondary to loss of epithelial signals.
| DISCUSSION |
|---|
|
|
|---|
|
Mesodermal Tbx1 is necessary and sufficient for cardiac outflow tract development
We have previously proposed that Tbx1 has a role in the expansion
of cardiomyocyte precursors, but we were not able to exclude that at least
part of the cardiac outflow tract phenotype may be due to reduced endodermal
expression (Xu et al., 2005
;
Xu et al., 2004
). This is
because the key Cre driver used in those experiments,
Nkx2.5Cre, induced recombination in a region of the
pharyngeal endoderm partially overlapping with Tbx1 expression
(Xu et al., 2004
). Here, we
show that mesodermal ablation recapitulated the OFT abnormalities seen in
Tbx1-/- embryos, whereas mesodermal Tbx1
restoration in a mutant background was sufficient to rescue those
abnormalities. These results suggest that the role of endoderm expression in
cardiac outflow development is marginal, if at all important, and assign the
crucial role to mesodermal expression. However, Arnold et al.
(Arnold et al., 2006
) have
shown that Tbx1 ablation using the
Foxg1Cre/+ driver results in a severe phenotype
(including OFT defects) resembling that of Tbx1-/-
animals. The report showed that this driver induced recombination
predominantly in the pharyngeal endoderm, suggesting a major role of
Tbx1 in this tissue for OFT development. We have shown that the
Foxg1Cre/+ driver induces robust recombination
not only in pharyngeal epithelia (endoderm and ectoderm) but also in
pharyngeal mesoderm and secondary heart field
(Zhang et al., 2005
). Arnold
et al. have used this driver in a different genetic background that clearly
has attenuated extra-endodermal recombination. However, it cannot be excluded
that residual recombination activity in the mesoderm might have reduced the
dose of Tbx1 in this tissue to a level that affects normal OFT
development.
Tissue-specific roles of Tbx1: not always a clear cut distinction
Ablation of a gene from individual interacting tissues may potentially lead
to similar morphological phenotypes without necessarily illuminating the role
of the gene in a particular tissue. The strategy used here, i.e.
tissue-specific gene reactivation in a mutant background, was designed to
diminish this problem. Mesp1Cre-driven deletion and
restoration of Tbx1 expression showed that Tbx1 has several
developmental roles that are confined to the mesoderm. However, the
development of the thymus, of the 3rd and 4th pharyngeal pouches, and of the
4th pharyngeal arch require both mesodermal and epithelial expression. Thus,
besides a cell-autonomous function in the mesoderm, Tbx1 may regulate
interactions between different tissues. Exactly how this role is effected
remains to be clarified, but considering that Tbx1 appears to
interact with several of the major signaling systems that play fundamental
roles in development, the candidate molecular pathways are manifold.
Mechanisms could include transcriptional regulation of genes encoding
extracellular ligands (Hu et al.,
2004
; Vitelli et al.,
2002b
; Xu et al.,
2004
) or of proteins involved in the catabolism of ligands
(Guris et al., 2006
;
Ivins et al., 2005
) or in
signal transduction (Park et al.,
2006
).
The fact that the Tbx1Neo2 allele is not null raises the issue of whether the rescue of some phenotypic abnormalities in the restoration experiments might have been `helped' by the residual expression of the neo2 allele in the endoderm and ectoderm. However, the observations that Tbx1neo2/- embryos have essentially the same phenotype as Tbx1-/- embryos and that Mesp1Cre/+;Tbx1flox/- animals also have a very severe and similar phenotype to Tbx1-/- embryos, suggest that reduced or full expression of Tbx1 in non-mesodermal tissues, although required for several developmental processes, cannot rescue phenotypic abnormalities caused by loss of mesodermal Tbx1 expression.
What is the role of Tbx1 in the mesoderm?
To understand the earliest molecular consequences of Tbx1 loss of
function in the mesoderm, we examined M-ko mutants at a stage previously shown
to be crucial for Tbx1 function. At this stage (E8.5), the morphology
of mutant embryos is normal but we found a strong reduction in cell
proliferation in the region of the pharyngeal mesenchyme that normally
expresses Tbx1. Such reduced proliferation could explain the strongly
reduced cellularity in the pharyngeal arches and the cardiac outflow tract
defects. Ataliotis et al. using lineage labeling experiments in
Xenopus, suggested that Tbx1 has a cell-autonomous function
in the pharyngeal mesoderm (Ataliotis et
al., 2005
).
We and others have proposed that the Tbx1 pro-proliferative activity may be
effected, at least in part, by regulating FGF ligand gene expression. This
view is supported by the demonstration that Tbx1 can indeed activate an
Fgf8 enhancer in tissue culture assays
(Hu et al., 2004
), and by the
genetic interaction between the two genes in vivo
(Vitelli et al., 2002b
;
Vitelli et al., 2006
). It has
been shown that conditional ablation of Fgf8 in the mesoderm can
cause OFT defects and reduce cell proliferation and survival
(Ilagan et al., 2006
;
Park et al., 2006
). We and
others have previously shown that Tbx1 is required for endodermal,
but not ectodermal, expression (Zhang et
al., 2005
), but Fgf8 expression in the mesoderm of
Tbx1 mutants had not been tested before. Here, we show that
mesodermal Tbx1 is required for Fgf8 expression in the
splanchnic mesoderm/anterior heart field region. Whether or not the loss of
Fgf8 in this tissue is sufficient to cause the OFT phenotype of M-ko
mutants is unknown. Mesp1Cre-driven deletion of
Fgf8 causes early lethality in most embryos, preventing the full
assessment of fetal consequences of this conditional mutation
(Park et al., 2006
). However,
Fgf8 knock-in into the Tbx1 locus was unable to rescue or
modify the OFT phenotype of Tbx1 mutants
(Vitelli et al., 2006
). In
addition, Fgf8 loss in mesoderm reduces cell survival and
proliferation, while Tbx1 mutation only affects proliferation.
Further complication of the relationship between Tbx1 and
Fgf8, is added by the report of downregulation of the FGF receptor
Fgfr1 RNA expression in Tbx1-/- mutants
(Park et al., 2006
). We
propose that a reduction of FGF signaling, resulting from cell autonomous
downregulation of ligand and receptor expression, has an important role in the
cell proliferation phenotype of Tbx1 mutants. However, the role of
other signaling systems should be investigated.
Overall, our data indicate a crucial role of the mesoderm in the pathogenesis of the DiGeorge-like phenotype and we show, for the first time, that the mesoderm has a direct influence on the proper morphogenesis of the pharyngeal pouches.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
| REFERENCES |
|---|
|
|
|---|
Albrecht, U., Eichele, G., Helms, J. A. and Lu, H. C. (1997). Visualization of gene expression patterns by in situ hybridization. In Molecular and Cellular Methods in Developmental Toxicology (ed. G. P. Daston), pp.23 -48. New York: CRC Press.
Arnold, J. S., Werling, U., Braunstein, E. M., Liao, J.,
Nowotschin, S., Edelmann, W., Hebert, J. M. and Morrow, B. E.
(2006). Inactivation of Tbx1 in the pharyngeal endoderm results
in 22q11DS malformations. Development
133,977
-987.
Ataliotis, P., Ivins, S., Mohun, T. J. and Scambler, P. J. (2005). XTbx1 is a transcriptional activator involved in head and pharyngeal arch development in Xenopus laevis. Dev. Dyn. 232,979 -991.[CrossRef][Medline]
Chapman, D. L., Garvey, N., Hancock, S., Alexiou, M., Agulnik, S. I., Gibson-Brown, J. J., Cebra-Thomas, J., Bollag, R. J., Silver, L. M. and Papaioannou, V. E. (1996). Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development. Dev. Dyn. 206,379 -390.[CrossRef][Medline]
Chen, A., Francis, M., Ni, L., Cremers, C. W., Kimberling, W. J., Sato, Y., Phelps, P. D., Bellman, S. C., Wagner, M. J., Pembrey, M. et al. (1995). Phenotypic manifestations of branchio-oto-renal syndrome. Am. J. Med. Genet. 58,365 -370.[CrossRef][Medline]
Crump, J. G., Maves, L., Lawson, N. D., Weinstein, B. M. and
Kimmel, C. B. (2004). An essential role for Fgfs in
endodermal pouch formation influences later craniofacial skeletal patterning.
Development 131,5703
-5716.
Giguere, V., Lyn, S., Yip, P., Siu, C. H. and Amin, S.
(1990). Molecular cloning of cDNA encoding a second cellular
retinoic acid-binding protein. Proc. Natl. Acad. Sci.
USA 87,6233
-6237.
Graham, A., Okabe, M. and Quinlan, R. (2005). The role of the endoderm in the development and evolution of the pharyngeal arches. J. Anat. 207,479 -487.[Medline]
Guris, D. L., Duester, G., Papaioannou, V. E. and Imamoto, A. (2006). Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev. Cell 10,81 -92.[CrossRef][Medline]
Hacker, A. and Guthrie, S. (1998). A distinct developmental programme for the cranial paraxial mesoderm in the chick embryo. Development 125,3461 -3472.[Abstract]
Helms, J. A. and Schneider, R. A. (2003). Cranial skeletal biology. Nature 423,326 -331.[CrossRef][Medline]
Hu, T., Yamagishi, H., Maeda, J., McAnally, J., Yamagishi, C.
and Srivastava, D. (2004). Tbx1 regulates fibroblast growth
factors in the anterior heart field through a reinforcing autoregulatory loop
involving forkhead transcription factors. Development
131,5491
-5502.
Hunt, P., Gulisano, M., Cook, M., Sham, M. H., Faiella, A., Wilkinson, D., Boncinelli, E. and Krumlauf, R. (1991a). A distinct Hox code for the branchial region of the vertebrate head. Nature 353,861 -864.[CrossRef][Medline]
Hunt, P., Whiting, J., Muchamore, I., Marshall, H. and Krumlauf, R. (1991b). Homeobox genes and models for patterning the hindbrain and branchial arches. Dev. Suppl. 1, 187-196.[Medline]
Ilagan, R., Abu-Issa, R., Brown, D., Yang, Y. P., Jiao, K.,
Schwartz, R. J., Klingensmith, J. and Meyers, E. N. (2006).
Fgf8 is required for anterior heart field development.
Development 133,2435
-2445.
Ivins, S., Lammerts van Beuren, K., Roberts, C., James, C., Lindsay, E., Baldini, A., Ataliotis, P. and Scambler, P. J. (2005). Microarray analysis detects differentially expressed genes in the pharyngeal region of mice lacking Tbx1. Dev. Biol. 285,554 -569.[CrossRef][Medline]
Jerome, L. A. and Papaioannou, V. E. (2001). DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1.Nat. Genet. 27,286 -291.[CrossRef][Medline]
Kelly, R. G., Jerome-Majewska, L. A. and Papaioannou, V. E.
(2004). The del22q11.2 candidate gene Tbx1 regulates
branchiomeric myogenesis. Hum. Mol. Genet.
13,2829
-2840.
Liao, J., Kochilas, L., Nowotschin, S., Arnold, J. S., Aggarwal,
V. S., Epstein, J. A., Brown, M. C., Adams, J. and Morrow, B. E.
(2004). Full spectrum of malformations in velo-cardio-facial
syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage.
Hum. Mol. Genet. 13,1577
-1585.
Lindsay, E. A. (2001). Chromosomal microdeletions: dissecting del22q11 syndrome. Nat. Rev. Genet. 2,858 -868.[CrossRef][Medline]
Lindsay, E. A., Vitelli, F., Su, H., Morishima, M., Huynh, T., Pramparo, T., Jurecic, V., Ogunrinu, G., Sutherland, H. F., Scambler, P. J. et al. (2001). Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410,97 -101.[CrossRef][Medline]
Merscher, S., Funke, B., Epstein, J. A., Heyer, J., Puech, A., Lu, M. M., Xavier, R. J., Demay, M. B., Russell, R. G., Factor, S. et al. (2001). TBX1 is responsible for cardiovascular defects in Velo-Cardio-Facial/DiGeorge Syndrome. Cell 104,619 -629.[CrossRef][Medline]
Noden, D. M. (1983). The role of the neural crest in patterning of avian cranial skeletal, connective, and muscle tissues. Dev. Biol. 96,144 -165.[CrossRef][Medline]
Noden, D. M. and Francis-West, P. (2006). The differentiation and morphogenesis of craniofacial muscles. Dev. Dyn. 235,1194 -1218.[CrossRef][Medline]
Nowotschin, S., Liao, J., Gage, P. J., Epstein, J. A., Campione,
M. and Morrow, B. E. (2006). Tbx1 affects asymmetric cardiac
morphogenesis by regulating Pitx2 in the secondary heart field.
Development 133,1565
-1573.
Park, E. J., Ogden, L. A., Talbot, A., Evans, S., Cai, C. L.,
Black, B. L., Frank, D. U. and Moon, A. M. (2006). Required,
tissue-specific roles for Fgf8 in outflow tract formation and remodeling.
Development 133,2419
-2433.
Piotrowski, T. and Nusslein-Volhard, C. (2000). The endoderm plays an important role in patterning the segmented pharyngeal region in zebrafish (Danio rerio). Dev. Biol. 225,339 -356.[CrossRef][Medline]
Piotrowski, T., Ahn, D. G., Schilling, T. F., Nair, S.,
Ruvinsky, I., Geisler, R., Rauch, G. J., Haffter, P., Zon, L. I., Zhou, Y. et
al. (2003). The zebrafish van gogh mutation disrupts tbx1,
which is involved in the DiGeorge deletion syndrome in humans.
Development 130,5043
-5052.
Roberts, C., Ivins, S. M., James, C. T. and Scambler, P. J. (2005). Retinoic acid down-regulates Tbx1 expression in vivo and in vitro. Dev. Dyn. 232,928 -938.[CrossRef][Medline]
Robin, N. H., Feldman, G. J., Aronson, A. L., Mitchell, H. F., Weksberg, R., Leonard, C. O., Burton, B. K., Josephson, K. D., Laxova, R., Aleck, K. A. et al. (1995). Opitz syndrome is genetically heterogeneous, with one locus on Xp22, and a second locus on 22q11.2. Nat. Genet. 11,459 -461.[CrossRef][Medline]
Saga, Y., Miyagawa-Tomita, S., Takagi, A., Kitajima, S., Miyazaki, J. and Inoue, T. (1999). MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube. Development 126,3437 -3447.[Abstract]
Saldivar, J. R., Krull, C. E., Krumlauf, R., Ariza-McNaughton, L. and Bronner-Fraser, M. (1996). Rhombomere of origin determines autonomous versus environmentally regulated expression of Hoxa-3 in the avian embryo. Development 122,895 -904.[Abstract]
Schneider, R. A. and Helms, J. A. (2003). The
cellular and molecular origins of beak morphology.
Science 299,565
-568.
Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre reporter strain [letter]. Nat. Genet. 21,70 -71.[CrossRef][Medline]
Stalmans, I., Lambrechts, D., De Smet, F., Jansen, S., Wang, J., Maity, S., Kneer, P., Von Der Ohe, M., Swillen, A., Maes, C. et al. (2003). VEGF: A modifier of the del22q11 (DiGeorge) syndrome? Nat. Med. 9,173 -182.[CrossRef][Medline]
Tam, P. P. and Trainor, P. A. (1994). Specification and segmentation of the paraxial mesoderm. Anat. Embryol. 189,275 -305.[Medline]
Trainor, P. A. and Tam, P. P. (1995). Cranial paraxial mesoderm and neural crest cells of the mouse embryo: co-distribution in the craniofacial mesenchyme but distinct segregation in branchial arches. Development 121,2569 -2582.[Abstract]
Trainor, P. and Krumlauf, R. (2000). Plasticity in mouse neural crest cells reveals a new patterning role for cranial mesoderm. Nat. Cell Biol. 2, 96-102.[CrossRef][Medline]
Trainor, P. A., Tan, S. S. and Tam, P. P.
(1994). Cranial paraxial mesoderm: regionalisation of cell fate
and impact on craniofacial development in mouse embryos.
Development 120,2397
-2408.
Trainor, P. A., Ariza-McNaughton, L. and Krumlauf, R.
(2002a). Role of the isthmus and FGFs in resolving the paradox of
neural crest plasticity and prepatterning. Science
295,1288
-1291.
Trainor, P. A., Sobieszczuk, D., Wilkinson, D. and Krumlauf, R. (2002b). Signalling between the hindbrain and paraxial tissues dictates neural crest migration pathways. Development 129,433 -442.
Veitch, E., Begbie, J., Schilling, T. F., Smith, M. M. and Graham, A. (1999). Pharyngeal arch patterning in the absence of neural crest. Curr. Biol. 9,1481 -1484.[CrossRef][Medline]
Vitelli, F., Morishima, M., Taddei, I., Lindsay, E. A. and
Baldini, A. (2002a). Tbx1 mutation causes multiple
cardiovascular defects and disrupts neural crest and cranial nerve migratory
pathways. Hum. Mol. Genet.
11,915
-922.
Vitelli, F., Taddei, I., Morishima, M., Meyers, E. N., Lindsay,
E. A. and Baldini, A. (2002b). A genetic link between Tbx1
and Fibroblast Growth Factor signaling. Development
129,4605
-4611.
Vitelli, F., Zhang, Z., Huynh, T., Sobotka, A., Mupo, A. and Baldini, A. (2006). Fgf8 expression in the Tbx1 domain causes skeletal abnormalities and modifies the aortic arch but not the outflow tract phenotype of Tbx1 mutants. Dev. Biol. 295,559 -570.[CrossRef][Medline]
Xu, H., Morishima, M., Wylie, J. N., Schwartz, R. J., Bruneau,
B. G., Lindsay, E. A. and Baldini, A. (2004). Tbx1 has a dual
role in the morphogenesis of the cardiac outflow tract.
Development 131,3217
-3227.
Xu, H., Cerrato, F. and Baldini, A. (2005).
Timed mutation and cell-fate mapping reveal reiterated roles of Tbx1 during
embryogenesis, and a crucial function during segmentation of the pharyngeal
system via regulation of endoderm expansion.
Development 132,4387
-4395.
Yagi, H., Furutani, Y., Hamada, H., Sasaki, T., Asakawa, S., Minoshima, S., Ichida, F., Joo, K., Kimura, M., Imamura, S.-I. et al. (2003). Role of TBX1 in human del22q11.2 syndrome. Lancet 362,1366 -1373.[CrossRef][Medline]
Yamagishi, H., Maeda, J., Hu, T., McAnally, J., Conway, S. J.,
Kume, T., Meyers, E. N., Yamagishi, C. and Srivastava, D.
(2003). Tbx1 is regulated by tissue-specific forkhead proteins
through a common Sonic hedgehog-responsive enhancer. Genes
Dev. 17,269
-281.
Zhang, Z., Cerrato, F., Xu, H., Vitelli, F., Morishima, M.,
Vincentz, J., Furuta, Y., Ma, L., Martin, J. F., Baldini, A. et al.
(2005). Tbx1 expression in pharyngeal epithelia is necessary for
pharyngeal arch artery development. Development
132,5307
-5315.
This article has been cited by other articles:
![]() |
M. Theveniau-Ruissy, M. Dandonneau, K. Mesbah, O. Ghez, M.-G. Mattei, L. Miquerol, and R. G. Kelly The del22q11.2 Candidate Gene Tbx1 Controls Regional Outflow Tract Identity and Coronary Artery Patterning Circ. Res., July 18, 2008; 103(2): 142 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang and A. Baldini In vivo response to high-resolution variation of Tbx1 mRNA dosage Hum. Mol. Genet., January 1, 2008; 17(1): 150 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Robertson, I. Charatsi, C. J. Joyner, C. H. Koonce, M. Morgan, A. Islam, C. Paterson, E. Lejsek, S. J. Arnold, A. Kallies, et al. Blimp1 regulates development of the posterior forelimb, caudal pharyngeal arches, heart and sensory vibrissae in mice Development, December 15, 2007; 134(24): 4335 - 4345. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. MAES, T. KOBAYASHI, and H. M. KRONENBERG A Novel Transgenic Mouse Model to Study the Osteoblast Lineage in Vivo Ann. N.Y. Acad. Sci., November 1, 2007; 1116(1): 149 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dong, X. Sun, W. Liu, D. Ai, E. Klysik, M.-F. Lu, J. Hadley, L. Antoni, L. Chen, A. Baldini, et al. Pitx2 promotes development of splanchnic mesoderm-derived branchiomeric muscle Development, December 15, 2006; 133(24): 4891 - 4899. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Roberts, S. Ivins, A. C. Cook, A. Baldini, and P. J. Scambler Cyp26 genes a1, b1 and c1 are down-regulated in Tbx1 null mice and inhibition of Cyp26 enzyme function produces a phenocopy of DiGeorge Syndrome in the chick Hum. Mol. Genet., December 1, 2006; 15(23): 3394 - 3410. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||